rs1369723667
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 1P and 6B. PP3BP6_ModerateBS2
The NM_021098.3(CACNA1H):c.3173T>C(p.Leu1058Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000481 in 1,454,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000048 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 missense
NM_021098.3 missense
Scores
3
10
6
Clinical Significance
Conservation
PhyloP100: 3.71
Publications
1 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.829
BP6
Variant 16-1208031-T-C is Benign according to our data. Variant chr16-1208031-T-C is described in ClinVar as Benign. ClinVar VariationId is 529609.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 7 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.3134T>C | p.Leu1045Pro | missense_variant | Exon 16 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.3134T>C | p.Leu1045Pro | missense_variant | Exon 16 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.3173T>C | p.Leu1058Pro | missense_variant | Exon 16 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*1086T>C | non_coding_transcript_exon_variant | Exon 16 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2620T>C | non_coding_transcript_exon_variant | Exon 15 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.3173T>C | non_coding_transcript_exon_variant | Exon 16 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000640028.1 | n.*1086T>C | 3_prime_UTR_variant | Exon 16 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2620T>C | 3_prime_UTR_variant | Exon 15 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD2 exomes AF: 0.0000255 AC: 6AN: 235594 AF XY: 0.0000312 show subpopulations
GnomAD2 exomes
AF:
AC:
6
AN:
235594
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000481 AC: 7AN: 1454084Hom.: 0 Cov.: 33 AF XY: 0.00000554 AC XY: 4AN XY: 722614 show subpopulations
GnomAD4 exome
AF:
AC:
7
AN:
1454084
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
722614
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33342
American (AMR)
AF:
AC:
7
AN:
43944
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25964
East Asian (EAS)
AF:
AC:
0
AN:
39338
South Asian (SAS)
AF:
AC:
0
AN:
84634
European-Finnish (FIN)
AF:
AC:
0
AN:
51760
Middle Eastern (MID)
AF:
AC:
0
AN:
5668
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1109322
Other (OTH)
AF:
AC:
0
AN:
60112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jun 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;.;.;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;.
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;M;M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D;D
REVEL
Pathogenic
Sift
Benign
T;.;T;T
Sift4G
Benign
T;.;T;T
Polyphen
D;.;D;D
Vest4
MutPred
Gain of disorder (P = 0.0216);.;Gain of disorder (P = 0.0216);Gain of disorder (P = 0.0216);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.